Real-World Evidence Confirms Risk Stratification of the 31-GEP and i31-GEP in Prospectively Tested Patients with Stage I-III Cutaneous Melanoma . J of Skin. 2024;8(2):s386. doi:10.25251/skin.8.supp.386